Globus Medical Schedules First Quarter Earnings Release and Conference Call
17 4월 2024 - 5:30AM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, will announce its financial results for the
first quarter ended March 31, 2024 after the market close on
Tuesday, May 7, 2024. A copy of the release will be
available on the Globus Medical website at
www.investors.globusmedical.com.
Following the announcement, Globus Medical will hold a
teleconference to discuss its performance with the investment
community at 4:30 p.m. Eastern Time. Participants may access the
conference call live via webcast on the Investors page of Globus
Medical’s website at
https://www.investors.globusmedical.com/news-events/events-webcasts.
To participate via telephone, please register in advance at this
link. Upon registration, all telephone participants will receive a
confirmation email detailing how to join the conference call,
including the dial-in number along with a unique passcode and
registrant ID that can be used to access the call.
The audio archive will be available after the call on the
Investor page of the Globus Medical website.
About Globus Medical, Inc.Globus Medical, Inc.
is a leading musculoskeletal solutions company based in Audubon,
PA. The company was founded in 2003 by an experienced team of
professionals with a shared vision to create products that enable
surgeons to promote healing in patients with musculoskeletal
disorders. Additional information can be accessed at
www.globusmedical.com.
Safe Harbor StatementsAll statements included
in this press release other than statements of historical fact are
forward-looking statements and may be identified by their use of
words such as “believe,” “may,” “might,” “could,” “will,” “aim,”
“estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan”
and other similar terms. These forward-looking statements are based
on our current assumptions, expectations and estimates of future
events and trends. Forward-looking statements are only predictions
and are subject to many risks, uncertainties and other factors that
may affect our businesses and operations and could cause actual
results to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, the risks and costs
associated with the integration of the NuVasive business and our
ability to successfully integrate and to achieve anticipated
synergies with the integration, health epidemics, pandemics and
similar outbreaks, factors affecting our quarterly results, our
ability to manage our growth, our ability to sustain our
profitability, demand for our products, our ability to compete
successfully (including without limitation our ability to convince
surgeons to use our products and our ability to attract and retain
sales and other personnel), our ability to rapidly develop and
introduce new products, our ability to develop and execute on
successful business strategies, our ability to comply with changes
and applicable laws and regulations that are or may become
applicable to our businesses, our ability to safeguard our
intellectual property, our success in defending legal proceedings
brought against us, trends in the medical device industry, general
economic conditions, and other risks. For a discussion of these and
other risks, uncertainties and other factors that could affect our
results, you should refer to the disclosure contained in our most
recent annual report on Form 10-K filed with the Securities and
Exchange Commission, including the sections labeled “Risk Factors”
and “Cautionary Note Concerning Forward-Looking Statements,” and in
our Forms 10-Q, Forms 8-K and other filings with the Securities and
Exchange Commission. These documents are available at www.sec.gov.
Moreover, we operate in an evolving environment. New risk factors
and uncertainties emerge from time to time and it is not possible
for us to predict all risk factors and uncertainties, nor can we
assess the impact of all factors on our business or the extent to
which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any
forward-looking statements. Given these risks and uncertainties,
readers are cautioned not to place undue reliance on any
forward-looking statements. Forward-looking statements contained in
this press release speak only as of the date of this press release.
We undertake no obligation to update any forward-looking statements
as a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contacts:
Investors:Brian KearnsSenior Vice President,
Business Development and Investor RelationsPhone: (610)
930-1800Email: investors@globusmedical.comwww.globusmedical.com
Media:Moran ChavezSenior Director, Corporate
AffairsPhone: (619) 318-7681Email: media@globusmedical.com
Globus Medical (NYSE:GMED)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Globus Medical (NYSE:GMED)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024